BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7806157)

  • 1. Effect of deoxycholate on immunoglobulin G concentration in bile: studies in humans and pigs.
    Sanabria JR; Upadhya A; Mullen B; Harvey PR; Strasberg SM
    Hepatology; 1995 Jan; 21(1):215-22. PubMed ID: 7806157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol crystallization in human gallbladder bile: relation to gallstone number, bile composition, and apolipoprotein E4 isoform.
    Van Erpecum KJ; Van Berge-henegouwen GP; Eckhardt ER; Portincasa P; Van De Heijning BJ; Dallinga-Thie GM; Groen AK
    Hepatology; 1998 Jun; 27(6):1508-16. PubMed ID: 9620320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The physical chemistry of cholesterol solubility in bile. Relationship to gallstone formation and dissolution in man.
    Carey MC; Small DM
    J Clin Invest; 1978 Apr; 61(4):998-1026. PubMed ID: 659586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic bile versus gallbladder bile: a comparison of protein and lipid concentration and composition in cholesterol gallstone patients.
    Keulemans YC; Mok KS; de Wit LT; Gouma DJ; Groen AK
    Hepatology; 1998 Jul; 28(1):11-6. PubMed ID: 9657090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biliary nonmucin glycoproteins in patients with and without gallstones.
    Lipsett PA; Fox-Talbot MK; Falconer SD; Tam ML; Magnuson TA; Lillemoe KD; Pitt HA
    J Surg Res; 1995 Apr; 58(4):386-90. PubMed ID: 7723316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biliary proteins and their redox status changes in gallstone patients.
    Grattagliano I; Wang DQ; Di Ciaula A; Diogo CV; Palasciano G; Portincasa P
    Eur J Clin Invest; 2009 Nov; 39(11):986-92. PubMed ID: 19656169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease.
    Holan KR; Holzbach RT; Hermann RE; Cooperman AM; Claffey WJ
    Gastroenterology; 1979 Oct; 77(4 Pt 1):611-7. PubMed ID: 467918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nucleation time and lithogenic index in obese patients and in patients with cholecystolithiasis].
    Janowitz P; Wechsler JG; Swobodnik W; Fischer S; Förstner J; Ditschuneit H
    Z Gastroenterol; 1988 Dec; 26(12):750-4. PubMed ID: 3245253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The possibility of prediction of cholesterol saturation of gallbladder bile].
    Han TQ
    Zhonghua Wai Ke Za Zhi; 1990 May; 28(5):285-8, 318. PubMed ID: 2086098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sluggish small bowel motility is involved in determining increased biliary deoxycholic acid in cholesterol gallstone patients.
    Azzaroli F; Mazzella G; Mazzeo C; Simoni P; Festi D; Colecchia A; Montagnani M; Martino C; Villanova N; Roda A; Roda E
    Am J Gastroenterol; 1999 Sep; 94(9):2453-9. PubMed ID: 10484008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro nucleation factors--mucus glycoprotein and proteins: changes and mechanisms in the process of sludge and gallstone formation].
    Zhang X
    Zhonghua Wai Ke Za Zhi; 1991 Feb; 29(2):121-5, 143-4. PubMed ID: 1864186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total protein content of human gallbladder bile: relation to cholesterol gallstone disease and effects of treatment with bile acids and aspirin.
    Sahlin S
    Eur J Surg; 1996 Jun; 162(6):463-9. PubMed ID: 8817223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deoxycholate and cholate modulate the source of cholesterol substrate for bile acid synthesis in the rat.
    Scheibner J; Fuchs M; Schiemann M; Stange EF
    Hepatology; 1995 Feb; 21(2):529-38. PubMed ID: 7843727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slow intestinal transit: a motor disorder contributing to cholesterol gallstone formation in the ground squirrel.
    Xu QW; Scott RB; Tan DT; Shaffer EA
    Hepatology; 1996 Jun; 23(6):1664-72. PubMed ID: 8675191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans.
    Loria P; Bozzoli M; Concari M; Guicciardi ME; Carubbi F; Bertolotti M; Piani D; Nistri A; Angelico M; Romani M; Carulli N
    Hepatology; 1997 Jun; 25(6):1306-14. PubMed ID: 9185744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The relationship between serum lipids, apolipoproteins level and bile lipids level, chemical type of stone].
    Fu X; Gong K; Shao X
    Zhonghua Yi Xue Za Zhi; 1995 Nov; 75(11):656-9, 708. PubMed ID: 8697083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased activity in the biliary Con A-binding fraction accounts for the difference in crystallization behavior in bile from Chilean gallstone patients compared with Dutch gallstone patients.
    Miquel JF; Van Der Putten J; Pimentel F; Mok KS; Groen AK
    Hepatology; 2001 Feb; 33(2):328-32. PubMed ID: 11172333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased dietary fat content accelerates cholesterol gallstone formation in the cholesterol-fed prairie dog.
    LaMorte WW; O'Leary DP; Booker ML; Scott TE
    Hepatology; 1993 Dec; 18(6):1498-503. PubMed ID: 8244276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile salts stimulate glycoprotein release by guinea pig gallbladder in vitro.
    O'Leary DP; Murray FE; Turner BS; LaMont JT
    Hepatology; 1991 May; 13(5):957-61. PubMed ID: 2030000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol enhances membrane-damaging properties of model bile by increasing the intervesicular-intermixed micellar concentration of hydrophobic bile salts.
    Narain PK; DeMaria EJ; Heuman DM
    J Surg Res; 1999 Jun; 84(1):112-9. PubMed ID: 10334899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.